Tadeja Tk Kotar - Infectious Diseases

Author Information

Tadeja Kotar is a researcher associated with the Department of Infectious Diseases at Ljubljana University Medical Center, located in Ljubljana, Slovenia. Her contributions to the field of infectious diseases are evidenced by her extensive research work, particularly notable within the Slovenian context.

Research Contributions

Tadeja Kotar has made significant contributions to the field of infectious diseases, with a focus on virology, bacteriology, and epidemiology. Her research encompasses a diverse array of topics including the molecular characterization of Echinococcus granulosus, the detection of SARS-CoV-2 in hospital wastewater, and the evaluation of treatments for hepatitis C. Her work has also extended to studying the clinical characteristics of influenza-like illnesses during pandemics and the role of procalcitonin in hantavirus infections. Her studies often bridge the gap between clinical practice and research, contributing valuable insights to public health strategies and infectious disease management.

Aliases

Tadeja Kotar is also known by several aliases in academic publications, including T Kotar, T. Kotar, and Tadeja Tk Kotar. These variations in her name may appear across different research papers and databases.

Publication and Citation Metrics

Metric	Value
Total Number of Papers	16
Total Citation Count	294
H-index	8

Publications:

Molecular Characterization of Echinococcus granulosus sensu lato from Humans in Slovenia

DOI: 10.3390/pathogens9070562

Year: 2020

Detection of SARS-CoV-2 RNA in hospital wastewater from a low COVID-19 disease prevalence area

DOI: 10.1016/j.scitotenv.2020.143226

Year: 2020

Evaluation of rectal swab use for the determination of enteric pathogens: a prospective study of diarrhoea in adults.

DOI: 10.1016/j.cmi.2018.09.026

Year: 2019

A novel reassortant mammalian orthoreovirus with a divergent S1 genome segment identified in a traveler with diarrhea.

DOI: 10.1016/j.meegid.2019.06.002

Year: 2019

THU-160-Outcomes of the national strategy on hepatitis C treatment with direct acting antivirals in a real-life setting: Results from a national survey in Slovenia

DOI: 10.1016/S0618-8278(19)30435-9

Year: 2019

Ureaplasma parvum and Ureaplasma urealyticum detected with the same frequency among women with and without symptoms of urogenital tract infection

DOI: 10.1007/s10096-015-2351-8

Year: 2015

P1188 A CHANGE IN LIFE-STYLE AFTER SUCCESSFUL TREATMENT OF CHRONIC HEPATITIS C IN PEOPLE WHO INJECT DRUGS

DOI: 10.1016/S0168-8278(14)61348-9

Year: 2014

Impact of Added Fluvastatin to Standard-of-Care Treatment on Sustained Virological Response in Naïve Chronic Hepatitis C Patients Infected with Genotypes 1 and 3

DOI: 10.1159/000354541

Year: 2013

Procalcitonin in hantavirus infections

DOI: 10.3109/00365513.2011.560675

Year: 2011

Clinical characteristics of adult patients with influenza-like illness hospitalized in general ward during Influenza A H1N1 pandemic 2009/2010

DOI: 10.1007/s00508-011-0054-4

Year: 2011

What Causes ARDS in Infectious Diseases?

What Are the Benefits of Personalized Medicine in Infectious Diseases?

How Does Personalized Medicine Apply to Infectious Diseases?

How to Combat Antimicrobial Resistance?

What Measures Can Individuals Take to Protect Themselves from Infectious Diseases?

What is a Rash?

What Can Be Done to Mitigate the Impact of Climate Change on Infectious Diseases?

What Are the Key Components of a One Health Approach?

What are the future prospects of Dengvaxia?

Can Climate Change Affect Food and Water Security?

Partnered Content Networks

Relevant Topics